Archives: Agenda

• Exploring how AI can support end-to-end clinical trial delivery, from protocol authoring and risk assessment through to data analysis and reporting
• Examining how historical trial outcomes, regulatory feedback, and operational data can be leveraged to improve planning, country selection, site strategy, and database design
• Understanding how AI-driven connectivity across departments can break down silos and create a more integrated approach to trial execution
• Discussing how organisations can operationalise AI strategically to future-proof clinical development processes rather than applying disconnected point solutions

Moderator: Andreas Panteli, Director, Clinical Trial Recruitment/ Operations, Novartis

1 seat available for event sponsor

Best 3 LinkedIn posts from day 1 with hashtag #CTO and @Clinical Trials in Oncology Event Series tagged will win a prize in day 2 morning’s prize draw during chair’s opening remarks. Deadline end of drinks reception day 1. You must be present to win!

• Leveraging adaptive trial designs to enhance evidence generation and patient outcomes for products using new routes of administration
• Exploring multiple funding strategies to sustain innovation in challenging market conditions
• CEO case study: Lessons learned from advancing innovative oncology therapies despite resource constraints
• Determining when sufficient clinical evidence exists to support accelerated approval and regulatory success

LinkedIn Prize Draw

To be in with a chance of winning our LinkedIn prize draw on day 2, post your most engaging and/or funniest photo from Day 1 of the conference on LinkedIn by 8:00pm on June 30^th.

Please include the hashtag #CTO and tag both:

• Clinical Trials in Oncology Event Series
• Arena International Events Group

We will shortlist three finalists, and the audience will vote for the winner during the Chairpersons’ Opening Remarks on Day 2.

Please note. You must be present in the room at 8:45am to claim the prize. If the winner is not present, the prize will be awarded to the next finalist in attendance.

• The Community Navigator (CN)- Patient Led Navigation demonstrating the feasibility
• Quantifiable Patient Improvement – increased Clinical Trials Knowledge and Beliefs Scale (CHEKS) scores
• Reframing Patient-Led Navigation – as a structured solution (option) vs traditional navigation model, to improve equity, patient experience, and engagement in oncology research

• Evolution of masking technology to achieve protease-mediated, tumor-specific drug activation
• Applications of masking technology in oncology and immunology, including the ubiquitous macrophage checkpoint, CD47, and cytokines
• Development of a China-inclusive early development path, including considerations of IITs, China IND, and US IND.

• Exploring the capability of Digital Display Labels (DDLs) and the benefits for Clinical Trial Supplies
• A demonstration of the functionality of DDLs; just in time labelling, lot and expiry update, multiple page count.
• Understanding the operational ability to securely & remotely update content and language.
• Integrating across IMP profiles, vials, bottles, blisters etc.